Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Mi Tang, Jiang-Hui Cai, Hao-Yang Diao, Wen-Mei Guo, Xiao Yang & ShaSha Xing. (2022) The progress of peptide vaccine clinical trials in gynecologic oncology. Human Vaccines & Immunotherapeutics 18:5.
Read now
Read now
Corina Ciobanasu. (2021) Peptides-based therapy and diagnosis. Strategies for non-invasive therapies in cancer. Journal of Drug Targeting 29:10, pages 1063-1079.
Read now
Read now
Hanadi Saliba, Béatrice Heurtault, Hasnaa Bouharoun-Tayoun, Vincent Flacher, Benoît Frisch, Sylvie Fournel & Soulaima Chamat. (2017) Enhancing tumor specific immune responses by transcutaneous vaccination. Expert Review of Vaccines 16:11, pages 1079-1094.
Read now
Read now
Alice Bergamini, Umberto Leone Roberti Maggiore, Simone Ferrero, Emanuela Rabaiotti, Riccardo Viganò, Micaela Petrone, Patrizia De Marzi, Stefano Salvatore, Massimo Candiani & Giorgia Mangili. (2015) Investigational therapies currently in Phase II clinical trials for the treatment of pelvic serous carcinomas. Expert Opinion on Investigational Drugs 24:3, pages 345-362.
Read now
Read now
Articles from other publishers (17)
Hongling Peng, Xiang He & Qiao Wang. (2022) Targeted drug delivery system for ovarian cancer microenvironment: Improving the effects of immunotherapy. Frontiers in Immunology 13.
Crossref
Crossref
Xue Bai, Zara Smith, Yuheng Wang, Sam Butterworth & Annalisa Tirella. (2022) Sustained Drug Release from Smart Nanoparticles in Cancer Therapy: A Comprehensive Review. Micromachines 13:10, pages 1623.
Crossref
Crossref
Priti Tagde, Agnieszka Najda, Kalpana Nagpal, Giriraj T. Kulkarni, Muddaser Shah, Obaid Ullah, Sebastian Balant & Md. Habibur Rahman. (2022) Nanomedicine-Based Delivery Strategies for Breast Cancer Treatment and Management. International Journal of Molecular Sciences 23:5, pages 2856.
Crossref
Crossref
Meghna Amrita Singh, Tarani Prakash Shrivastava, Ajay Sharma & Madhu Gupta. 2022. Nanotherapeutics in Cancer Vaccination and Challenges. Nanotherapeutics in Cancer Vaccination and Challenges
295
311
.
Seth-Frerich Fobian, Ziyun Cheng & Timo L. M. ten Hagen. (2021) Smart Lipid-Based Nanosystems for Therapeutic Immune Induction against Cancers: Perspectives and Outlooks. Pharmaceutics 14:1, pages 26.
Crossref
Crossref
Orsolya Lőrincz, József Tóth, Levente Molnár, István Miklós, Kata Pántya, Mónika Megyesi, Eszter Somogyi, Zsolt Csiszovszki & Enikő R. Tőke. (2021) In Silico Model Estimates the Clinical Trial Outcome of Cancer Vaccines. Cells 10:11, pages 3048.
Crossref
Crossref
Rasmita DASH & Sujata MOHAPATRA. (2021) A contemporary insight into SARS-CoV-2 pathophysiology, retrieved threat of mutants and prospect of vaccine development. Minerva Biotechnology and Biomolecular Research 33:3.
Crossref
Crossref
Nehil Shreyash, Muskan Sonker, Sushant Bajpai & Saurabh Kr Tiwary. (2021) Review of the Mechanism of Nanocarriers and Technological Developments in the Field of Nanoparticles for Applications in Cancer Theragnostics. ACS Applied Bio Materials 4:3, pages 2307-2334.
Crossref
Crossref
Anna Lucia Tornesello, Maria Tagliamonte, Maria Lina Tornesello, Franco M. Buonaguro & Luigi Buonaguro. (2020) Nanoparticles to Improve the Efficacy of Peptide-Based Cancer Vaccines. Cancers 12:4, pages 1049.
Crossref
Crossref
Chenming Zou, Guiying Jiang, Xueqin Gao, Wei Zhang, Huan Deng, Chong Zhang, Jiahui Ding, Rui Wei, Xueqian Wang, Ling Xi & Songwei Tan. (2019) Targeted co-delivery of Trp-2 polypeptide and monophosphoryl lipid A by pH-sensitive poly (β-amino ester) nano-vaccines for melanoma. Nanomedicine: Nanotechnology, Biology and Medicine 22, pages 102092.
Crossref
Crossref
Hua Wang & David J. Mooney. (2018) Biomaterial-assisted targeted modulation of immune cells in cancer treatment. Nature Materials 17:9, pages 761-772.
Crossref
Crossref
Samaresh Sau, Katyayani Tatiparti, Hashem O. Alsaab, Sushil K. Kashaw & Arun K. Iyer. (2018) A tumor multicomponent targeting chemoimmune drug delivery system for reprograming the tumor microenvironment and personalized cancer therapy. Drug Discovery Today 23:7, pages 1344-1356.
Crossref
Crossref
Sepideh Parvizpour, Jafar Razmara & Yadollah Omidi. (2018) Breast cancer vaccination comes to age: impacts of bioinformatics. BioImpacts 8:3, pages 223-235.
Crossref
Crossref
Samaresh Sau, Hashem O. Alsaab, Ketki Bhise, Rami Alzhrani, Ghazal Nabil & Arun K. Iyer. (2018) Multifunctional nanoparticles for cancer immunotherapy: A groundbreaking approach for reprogramming malfunctioned tumor environment. Journal of Controlled Release 274, pages 24-34.
Crossref
Crossref
Qingyun Wei, Ju Li, Feng Tang, Yin Yin, Yong Zhao & Qizheng Yao. (2018) Synthesis and biological evaluation of novel 2-arylvinyl-substituted naphtho[2,3- d ]imidazolium halide derivatives as potent antitumor agents. European Journal of Medicinal Chemistry 144, pages 504-516.
Crossref
Crossref
Yu-Feng Xiao, Meng-Meng Jie, Bo-Sheng Li, Chang-Jiang Hu, Rui Xie, Bo Tang & Shi-Ming Yang. (2015) Peptide-Based Treatment: A Promising Cancer Therapy. Journal of Immunology Research 2015, pages 1-13.
Crossref
Crossref
Adriano Fernando Araújo, Gabriel de Oliveira, Juliana Fraga Vasconcelos, Jonatan Ersching, Mariana Ribeiro Dominguez, José Ronnie Vasconcelos, Alexandre Vieira Machado, Ricardo Tostes Gazzinelli, Oscar Bruna-Romero, Milena Botelho Soares & Mauricio Martins Rodrigues. (2014)
Genetic Vaccination against Experimental Infection with Myotropic Parasite Strains of
Trypanosoma cruzi
. Mediators of Inflammation 2014, pages 1-13.
Crossref
Crossref